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Abstract
Background Many associations between abdominal aortic aneurysm (AAA) and genetic polymorphisms have been reported. It is unclear which are genuine and which may be caused by type-1 errors, biases and flexible study design.
Objectives
To identify associations supported by current evidence and to investigate the effect of study design on reporting associations.
Data Sources
MEDLINE, Embase and Web of Science.
It has been claimed that most published research findings are false and that studies of complex genetic diseases are especially prone to reporting false associations. 1 Abdominal aortic aneurysms (AAA) occur in Mendelian disorders, 2 but are usually multifactorial. Understanding AAA pathogenesis might lead to new treatments or preventive measures. No meaningful personalised genetic risk prediction 3 has been realised for AAA.
AAA is usually defined as infra-renal aortic diameter ≥30mm. 4 Using alternative definitions (infrarenal aortic diameter:suprarenal aortic diameter ratio, or comparison to predicted diameter) has striking effects on prevalence. 5 Participants may be recruited from screening programmes or surgical departments, affecting case-mix.
The prevalence of old age, tobacco use and medication use has changed over time and differs between locations, so gene-environment interactions could affect results. [6] [7] [8] Ioannidis claimed that six factors increased the likelihood of research findings being false: small study size; small effect size; multiple testing; flexible study design; financial or other interests and the 'hotness' of the field. 1 The STrengthening the REporting of Genetic Association Studies (STREGA) guidance aims to make reports consistent and transparent, 9 but there is variation in the analytic and statistical methods used. This study aimed to identify gene associations supported by evidence and to investigate the role of study design in reporting associations.
Methods

Search Strategy
We searched databases using MeSH terms (Table 1 ; Supplementary Methods) on 25 August 2014. The Medline search was simply "Aortic Aneurysm, Abdominal/ge [Genetics]", limited to human studies. The National Institutes of Health association database, references and relevant journals were also searched.
Inclusion Criteria
 Population: cases with AAA (infrarenal aorta >30mm, infra-renal/supra-renal aortic ratio ≥1.5, surgical repair or ruptured AAA); controls were untested individuals, tested controls or hospital controls.
 Exposure: germline genomic polymorphisms.
 Comparison: disease risk in individuals with/without polymorphisms or odds of exposure in individuals with/without AAA in case-control, cross-sectional or cohort studies.
 Outcome: presence/absence of AAA.
Exclusion Criteria
Studies with single-disease controls (e.g. ischaemic heart disease), studies of somatic mutations, linkage studies and studies of AAA growth or size were excluded.
Study Selection and Data Abstraction
Two authors independently assessed titles and abstracts for relevance and full reports for inclusion. Two authors independently extracted quality and genotype/risk data for polymorphisms reported ≥2 times with an association reported at least once.
Additional characteristics were abstracted by one author
Data analysis
Median study size was calculated for each year. Odds ratios for heterozygotes and homozygotes were calculated. Where genotype counts were not available, inheritance models from original reports were used. Additive model analyses were conducted using binary logistic regression in IBM SPSS Statistics v19.0 (IBM Corp, Armonk, NY), with genotypes coded as 0, 1 or 2. We re-analysed original CRP data from Badger et al. 10 to allow meta-analysis with the results of Saratzis et al.. 11 Hardy
Weinberg Equilibrium (HWE) deviation was assessed by Haldane's Exact test in
HardyWeinberg in R. Sensitivity analyses excluded studies with HWE deviation (p<0.05). SNP Annotation and Proxy Search (Broad Institute, Cambridge, Massachussetts) identifed markers with r 2 >0.9. Where study data were published more than once (i.e. a study was updated or reported study populations overlapped), the selection of the report for inclusion was based on the reporting of genotype counts/frequencies or risk in preference to allelic or specific inheritance models. If the mode of reporting was the same then the larger study was included.
Heterogeneity index (I 2 ) and Cochrane's Q were estimated using meta in R. I 2 >50%
was large, and 25-50% moderate. 12 Fixed and random effects inverse varianceweighted meta-analysis was conducted using meta in R. Significance was p<0.05 in fixed effects meta-analysis if I 2 <25% or random effects meta-analysis if I 2 ≥25%.
Results
Search results
Searches yielded 614 records. Ten were identified from other sources. There were 477 unique records. Ninety seven were included ( Figure 1 ). Excluded studies are listed ( Supplementary Table 1 ).
Study types and reports of associations
There were 91 candidate gene studies, four genome-wide association studies (GWAS) and two genetic risk score (GRS) studies ( Table 2) . Fifty six candidate studies, both GRS and all GWAS reported associations.
Study size and frequency
Median study size for a candidate gene or GRS study was 710 participants (range 91-83,024). Study size and frequency of reports increased over time ( Figure 2 ).
There was a median of three reports/year between 1994 and 25 August 2014.
Study quality
Quality indicators (Table 2 ) and detailed characteristics (Supplementary Table 2 ) are shown. Sixty two studies (64%) reported an association. Ninety two studies reported multiple tests and 25 (27%) adjusted analyses for this.
Genes investigated
Two hundred and sixty three genes were investigated ( Supplementary Table 3 ), with 87 associated at least once. The median study size for reports that claimed an association was 811, and that of those that did not was 710 (Independent Samples Mann-Whitney U standardised test statistic=0.10, p=0.92).
Selection of polymorphisms for meta-analysis
We identified genes that featured in at least two studies and that had at least one association with sufficient data ( Supplementary Table 3 ; Supplementary Table 4 ).
Results of meta-analyses
Meta-analyses are summarised (Table 3) and shown in full (Supplementary Table 5 ).
Associations between AAA and 9p21 rs10757278, SORT1 rs599839, LRP1 rs1466535, MMP3 rs3025058, AGTR1 rs5186, ACE rs4646994 and APOA1 rs964184 were supported. CRP rs3091244 lost significance in sensitivity analysis.
MMP2 rs243865 was associated but one of two studies deviated from HWE. Six were supported by strong evidence, three by moderate evidence and 25 had weak evidence ( Table 4 ).
Discussion
Most studies reported associations, but only six were supported by strong evidence.
Two were reported in genome-wide studies (DAB2IP and LRP1), 72, 78 and four in candidate gene studies (9p21/CDKN2BAS, IL6R, LPA and SORT1). 50, 93, 94, 108 There was moderate evidence for associations with LDLR, MMP3 and AGTR1 polymorphisms. MMP3 rs3025058 was tentatively suggested to be an AAA risk factor in 1999 in a small study by Yoon et al. though it was not statistically significant after correction for multiple testing. 18 Subsequent studies appear to support its effect in homozygosity. Other associations currently supported by moderate or strong evidence were all made since 2008.
Inter-study inconsistency may be due to heterogeneity of effect, systematic error or bias. Multiple testing was usually uncorrected and flexible analysis was common:
Many studies tested numerous inheritance models and subgroups, reporting significance when p<0.05. Several studies claimed HWE, but deviated significantly (p<0.05). 11, 99 We propose that it may be time for the genetic epidemiology research community to consider prospective registration of aetiological studies to avoid flexible post hoc analyses. Simple standard steps, such as planning for adequate power, using contemporaneous controls and presenting counts and risk estimates for genotypes rather than assuming models of inheritance, checking frequencies in population databases, presenting analyses of HWE deviation and correcting for multiple testing would greatly improve the quality of reports in this field.
Our review excluded studies of aneurysm size or growth, and did not attempt to integrate results for 27 associated polymorphisms that had been reported only once.
Supported associations suggest the importance of lipoproteins. LRP1, LDLR, SORT1 and the 9p21 locus affect cholesterol metabolism and atherosclerosis. LRP1 has other important regulatory roles, including regulation of extracellular matrix breakdown by the endocytosis of proteinases. 109 LPA produces lipoprotein A which increases cardiovascular risk. 110 IL6R polymorphisms alter cardiovascular risk, possibly through inflammation. [111] [112] [113] [114] MMP3 affects atherosclerosis and tissue remodelling. 115 Its association in this review is in agreement with a recent metaanalysis. 116 AGTR1 affects blood pressure, which is consistent with the association between hypertension and AAA. 6, 117 DAB2IP is a tumour-suppressor gene involved in cell signalling, survival, migration, maturation and apoptosis. 72 Understanding their roles may help develop prevention strategies based on understanding key biological pathways. Improving future study design will avoid wasteful false associations. rs7635818
Figures
Legend to Figure 1 : PRISMA flowchart for Systematic Review Legend to Figure 2 : Study frequency and median study size, 1994-2014
